Price
No data yet.
Social Signal Score
Revenue
$1.25M+668.85%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Dennis Calvert
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Employees
- 45
- Beta
- -0.13
- Country
- US
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- -41.86
Financials
Revenue
$1.25M+668.8%Net Income
$-2.77MEBITDA
$-3.62MFree Cash Flow
$-3.02MEPS (diluted)
$-0.01Shares Outstanding (diluted)
320.98M+264.1%Operating Expenses
$4.40MCash & Debt
$2.19MReturn of Capital
$87.0KRevenue by Segment (annual)
$7.76MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $7.76M | $-11.78M | $-0.04 |
| 2024 | $17.78M | $-2.40M | $-0.01 |
| 2023 | $12.23M | $-3.50M | $-0.01 |
| 2022 | $5.88M | $-4.50M | $-0.02 |
| 2021 | $2.53M | $-7.38M | $-0.03 |
| 2020 | $2.43M | $-10.47M | $-0.05 |
| 2019 | $1.86M | $-14.75M | $-0.10 |
| 2018 | $1.36M | $-10.22M | $-0.08 |
| 2017 | $516.2K | $-9.12M | $-0.09 |
| 2016 | $281.1K | $-7.84M | $-0.09 |
| 2015 | $127.6K | $-5.06M | $-0.06 |
| 2014 | $111.5K | $-3.69M | $-0.05 |
| 2013 | $167.9K | $-2.53M | $-0.03 |
| 2012 | $65.5K | $-5.33M | $-0.08 |
Valuation
BLGOhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
120+20.00%Social Signal Score
Mentions (6)
- Newsseekingalpha.com·25d ago·Positive
BioLargo, Inc. (BLGO) Q2 2026 Earnings Call Transcript BioLargo, Inc. (BLGO) Q2 2026 Earnings Call Transcript
View source ↗ - Newsaccessnewswire.com·27d ago·Neutral
…ts Webcast and Conference Call on Thursday, September 10th, 2026 - 4:00 PM Eastern Time WESTMINSTER, CA / ACCESS Newswire / September 9, 2026 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host a townhall and investor webcast and conference call on Thursday, September 10th, 2026, at 1:00 pm Pacific / 4:00 pm Eastern. The event, which will be open to the public, will be held for an extended questions and…
View source ↗ - Newsaccessnewswire.com·33d ago·Negative
…e market, supplementing existing U.S. commercial distribution and 18 foreign countries. WESTMINSTER, CA / ACCESS Newswire / September 3, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences company, today announced that its subsidiary Clyra Medical Technologies is expanding distribution of its FDA-cleared ViaCLYR™ wound irrigation solution through a new Reseller Agreement with Spartan Medical Inc., opening a dedicated commercial channel to U.S. government healthcare facilities world…
View source ↗ - Newsaccessnewswire.com·35d ago·Neutral
BioLargo, Inc. to Present at the Inaugural Nasdaq / LD Micro Summit on September 9, 2026 WESTMINSTER, CA / ACCESS Newswire / September 1, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator and engineering services solution provider, today announced that Dennis P. Calvert, President and Chief Executive Officer, will participate in the inaugural Nasdaq / LD Micro Summit on Wednesday, September 9, 2026.
View source ↗ - Newsaccessnewswire.com·42d ago·Neutral
BioLargo to Participate in Gabelli Funds' 4th Annual PFAS Symposium in New York Former U.S. EPA senior executive Sally Gutierrez will represent BioLargo at the investor event. WESTMINSTER, CA / ACCESS Newswire / August 25, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences company, today announced that it will participate in Gabelli Funds' 4th Annual PFAS Symposium on September 24, 2026, in New York City.
View source ↗ - Newsaccessnewswire.com·49d ago·Neutral
…d of a Second Product Launch; Company to Host Stockholder Town Hall on September 10, 2026 WESTMINSTER, CA / ACCESS Newswire / August 17, 2026 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, today announced that it has filed its Quarterly Report on Form 10-Q for the three and six months ended June 30, 2026, and that it will host a stockholder town hall on Thursday, September 10, 2026, at 1:00 …
View source ↗
Earnings
Wed, Nov 18(in 6 weeks)
Consensus estimate $-0.01 per share
Typical surprise +0.0% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Aug 14$-0.01 vs $-0.01beat
- Fri, May 15$-0.01 vs $-0.01beat
- Wed, Mar 4$-0.01 vs $-0.01beat
- Thu, Aug 14$-0.00 vs $-0.01beat
Estimates and results for BLGO via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by BLGO officers and directors.
No open-market trades in the recent filings. All 100 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
100 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in BLGO.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.